Skip to content

Clinical trials

Phase 3 Ischemic Stroke trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 3 Country / region: Belgium Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20122
20141
20181
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
CSL Behring1
H. Lundbeck A/S1
Insel Gruppe AG, University Hospital Bern1
Janssen Research & Development, LLC1
Pierre Fabre Medicament1
Universitätsklinikum Hamburg-Eppendorf1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke7
Stroke4
Acute Coronary Syndrome1
Atherosclerosis1
Atrial Fibrillation1
Cardiovascular Diseases1
Cerebrovascular Disorders1
Coronary Artery Disease1
Heart Diseases1
Heart Failure1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.